Biomarkers to personalize treatment with 177Lu-PSMA-617 in men with metastatic castration-resistant prostate cancer-a state of the art review

Colaboración

Año: 2022

Heidegger, I; Kesch, C; Kretschmer, A; Tsaur, I; Ceci, F; Valerio, M; Tilki, D; Marra, G; Preisser, F; Fankhauser, CD; Zattoni, F; Chiu, P; Puche-Sanz, I; Olivier, J; van den Bergh, RCN; Kasivisvanathan, V; Pircher, A; Virgolini, I; Gandaglia, G

Título: THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY

• Q2